Novalis LifeSciences
Portsmouth, United States22
63M
16
3.67
4
0.23
2
- Areas of investment
Investor highlights
- Industry focus
- Stage focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Last fund
- Fund size
- USD 300000000
- Fund raised date
- 2021-12-08
Analytics
- Total investments
- 22
- Lead investments
- 4
- Exits
- 2
- Rounds per year
- 3.67
- Follow on index
- 0.23
- Investments by industry
- Biotechnology (18)
- Therapeutics (8)
- Agriculture (5)
- Health Care (5)
- Medical Device (4) Show 13 more
- Investments by region
- United States (16)
- United Kingdom (1)
- Belgium (3)
- Netherlands (1)
- Peak activity year
- 2022
- Number of Minotaurs
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 7
- Avg. valuation at time of investment
- 22M
- Group Appearance index
- 0.95
- Avg. company exit year
- 8
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| BlueWhale Bio | 07 Sep 2023 | Biotechnology, Manufacturing | Seed | 18M | United States, Pennsylvania, Philadelphia |
| MysteryVibe | 01 May 2018 | Health Care, Wellness, Product Design, Personal Health, Toys | Seed | 2M | United Kingdom, London, England |
| Vizgen | 07 Apr 2021 | Biotechnology | Early Stage Venture | 37M | United States, Massachusetts, Cambridge |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.